Evidence map›Paper›PMID 34833238›Full record

ArticlePolymers2021

Usefulness of a Nanostructured Fibrin-Agarose Bone Substitute in a Model of Severely Critical Mandible Bone Defect.

Miguel-Angel Martin-Piedra, Belén Gironés-Camarasa, Antonio España-López, Ricardo Fernández-Valadés Gámez, Cristina Blanco-Elices, Ingrid Garzón, Miguel Alaminos, Ricardo Fernández-Valadés

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Miguel-Angel Martin-PiedraTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, E18016 Granada, Spain.ORCID 0000-0002-4639-3175
Belén Gironés-CamarasaDivision of Pediatric Surgery, University Hospital Virgen de las Nieves, E18014 Granada, Spain.
Antonio España-LópezCraniofacial Malformations and Cleft Lip and Palate Management Unit, University Hospital Virgen de las Nieves, E18014 Granada, Spain.
Ricardo Fernández-Valadés GámezDivision of Oral and Maxillofacial Surgery, San Pedro Hospital, La Rioja, E26006 Logroño, Spain.
Cristina Blanco-ElicesTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, E18016 Granada, Spain.ORCID 0000-0003-0992-0113
Ingrid GarzónTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, E18016 Granada, Spain.
Miguel AlaminosTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, E18016 Granada, Spain.ORCID 0000-0003-4876-2672
Ricardo Fernández-ValadésInstituto de Investigación Biosanitaria ibs.GRANADA, E18012 Granada, Spain.
Universidad de Granada · ESHospital San Pedro · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Biosanitaria de Granada · ES

Funding

Consejería de Salud y Familias PI-0442-2019Instituto de Salud Carlos III FIS PI18/0331Instituto de Salud Carlos III FIS PI18/0332Instituto de Salud Carlos III FIS PI21/0980Instituto de Salud Carlos III ICI19/00024
6 · The paper itself

Abstract

Critical defects of the mandibular bone are very difficult to manage with currently available materials and technology. In the present work, we generated acellular and cellular substitutes for human bone by tissue engineering using nanostructured fibrin-agarose biomaterials, with and without adipose-tissue-derived mesenchymal stem cells differentiated to the osteogenic lineage using inductive media. Then, these substitutes were evaluated in an immunodeficient animal model of severely critical mandibular bone damage in order to assess the potential of the bioartificial tissues to enable bone regeneration. The results showed that the use of a cellular bone substitute was associated with a morpho-functional improvement of maxillofacial structures as compared to negative controls. Analysis of the defect site showed that none of the study groups fully succeeded in generating dense bone tissue at the regeneration area. However, the use of a cellular substitute was able to improve the density of the regenerated tissue (as determined via CT radiodensity) and form isolated islands of bone and cartilage. Histologically, the regenerated bone islands were comparable to control bone for alizarin red and versican staining, and superior to control bone for toluidine blue and osteocalcin in animals grafted with the cellular substitute. Although these results are preliminary, cellular fibrin-agarose bone substitutes show preliminary signs of usefulness in this animal model of severely critical mandibular bone defect.

Indexed as

bonefibrin-agarosemandibleregenerationtissue engineering

Identifiers

PMID34833238
PMCPMC8618832
OpenAlexW3212259231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.